Currie Mark G 4
4 · IRONWOOD PHARMACEUTICALS INC · Filed Jun 5, 2020
Insider Transaction Report
Form 4
Currie Mark G
Chief Scientific Officer
Transactions
- Award
Class A Common Stock
2020-06-03+21,720→ 570,992 total
Footnotes (1)
- [F1]The restricted stock, granted pursuant to the Director Compensation Policy effective May 2019, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year.